| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2009 | The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma | ZHONG-ZHE LIN ; Hsu H.-C.; CHIH-HUNG HSU ; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; SUNG-HSIN KUO ; CHIUN HSU ; Hu F.-C.; YUNG-MING JENG ; Chung Y.; ANN-LII CHENG | Journal of Hepatology | 38 | 39 | |
| 2002 | Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells | Chuang S.-E.; Yeh P.-Y.; YEN-SHEN LU ; Lai G.-M.; Liao C.-M.; Gao M.; ANN-LII CHENG | Biochemical Pharmacology | 153 | 135 | |
| 2009 | Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway | Chen K.-F.; Yeh P.-Y.; CHIUN HSU ; CHIH-HUNG HSU ; YEN-SHEN LU ; Hsieh H.-P.; PEI-JER CHEN ; ANN-LII CHENG | Journal of Biological Chemistry | 89 | 83 | |
| 2017 | Cholesterol Levels Are Associated with 30-day Mortality from Ischemic Stroke in Dialysis Patients | B.-S. Yip ; Liu C.-H.; Yen T.-H.; JIANN-SHING JENG ; Hsu S.-P.; Chen C.-H.; Lien L.-M.; Lin R.-T.; Chen A.-C.; Lin H.-J.; Chi H.-Y.; Lai T.-C.; Sun Y.; Lee S.-P.; Sung S.-F.; Chen P.-L.; Lee J.-T.; Chiang T.-R.; Lin S.-K.; Muo C.-H.; Ma H.; Wen C.-P.; Sung F.-C.; Hsu C.Y.; Tsai C.-H.; Huang W.-S.; Lu C.-T.; Tsai T.-C.; Tseng C.-H.; Lin K.-H.; Shyn W.-C.; Yang Y.-W.; Liu Y.-L.; Cho D.-Y.; Chen C.-C.; SUNG-CHUN TANG ; LI-KAI TSAI ; SHIN-JOE YEH ; Chen H.-J.; Chang C.-S.; Kuo H.-C.; Lee L.-H.; Tsui H.-W.; Tsou J.-C.; Wang Y.-T.; Tai Y.-C.; Tsai K.-C.; Chen Y.-W.; Lu K.; Liliang P.-C.; Tsai Y.-T.; Liang C.-L.; Wang K.-W.; Wang H.-K.; Chen J.-S.; Chen P.-Y.; Chye C.-L.; Tzeng W.-J.; Wu P.-H.; Sung P.-S.; Hsieh H.-C.; Su H.-C.; Chiu H.-C.; Chen W.-H.; Bai C.-H.; Huang T.-H.; Lau C.-I.; Wu Y.-Y.; Yeh H.-L.; Chang A.; Lin C.-H.; Yen C.-C.; Khor G.-T.; Chao A.-C.; Lin H.-F.; Huang P.; Ke D.-S.; Chang C.-Y.; Yeh P.-S.; Lin K.-C.; Cheng T.-J.; Chou C.-H.; Yang C.-M.; Shen H.-C.; Tsai S.-J.; Lu T.-M.; Kung S.-L.; Lee M.-J.; Chou H.-H.; Pan C.-H.; Chan P.-C.; Hsu M.-H.; Chang W.-L.; Huang Z.-Z.; Shoung H.-M.; Lo Y.-C.; Wang F.-H.; Yin J.-H.; Wang C.-J.; Wang K.-C.; Chen L.-M.; Denq J.-C.; Lu C.-J.; Huang C.-C.; Chan H.-F.; Sun M.-H.; Ke L.-Y.; Lee Y.-S.; Ong C.-T.; Wu C.-S.; Hsu Y.-C.; Su Y.-H.; Hung L.-C.; Lin J.-C.; Hsu Y.-D.; Peng G.-S.; Hsu C.-H.; Lin C.-C.; Yen C.-H.; Cheng C.-A.; Sung Y.-F.; Chen Y.-L.; Lien M.-T.; Liu C.-C.; Yang F.-C.; Wu Y.-C.; Tso A.-C.; Lai Y.-H.; Chiang C.-I.; Tsai C.-K.; Liu M.-T.; Lin Y.-C.; Hsu Y.-C.; Lee M.-C.; Huang P.-H.; Lie S.-K.; Liao P.-W.; Chen J.-T.; Sun M.-C.; Lai T.-P.; Chen W.-L.; Chen Y.-C.; Chen T.-C.; Wang W.-F.; Lee K.-W.; Lai C.-H.; Shih S.-Y.; Chuang C.-S.; Chen Y.-Y.; Chen C.-M.; Su Y.-C.; Hsiao C.-L.; Yang F.-Y.; Liu C.-Y.; Chiang H.-L.; Lin I.-S.; Chien C.-H.; Chang Y.-C.; Chen P.-K.; Chiu P.-Y.; Hsiao Y.-J.; Fang C.-W.; Lee K.-Y.; Lin Y.-Y.; Li C.-H.; Tsai H.-F.; Hsieh C.-F.; Yang C.-D.; Liaw S.-J.; Liao H.-C.; Wu L.-L.; Hsieh L.-P.; Lee Y.-H.; Chen C.-W.; Hsu C.-S.; Jhih Y.-J.; Zhuang H.-Y.; Pan Y.-H.; Shih S.-A.; Chen C.-I.; Sung J.-Y.; Weng H.-Y.; Teng H.-W.; Lee J.-E.; Huang C.-S.; Chao S.-P.; Yuan R.-Y.; Sheu J.-J.; Yu J.-M.; Ho C.-S.; Lin T.-C.; Yu S.-C.; Chen J.-R.; Tsai S.-Y.; Wei C.-Y.; Yang C.-N.; Hung C.-H.; Shih I.; Tseng H.-P.; Lin C.-L.; Lin H.-C.; Chen P.-T.; Hu C.-J.; Chi N.-F.; Chan L.; Chern C.-M.; Lin C.-J.; Wang S.-J.; Hsu L.-C.; Wong W.-J.; Lee I.-H.; Yen D.-J.; Tsai C.-P.; Kwan S.-Y.; Soong B.-W.; Chen S.-P.; Liao K.-K.; Lin K.-P.; Chen C.; Shan D.-E.; Fuh J.-L.; Wang P.-N.; Lee Y.-C.; Yu Y.-H.; Huang H.-C.; Tsai J.-Y.; Wu M.-H.; Chen S.-C.; Chiang S.-Y.; Wang C.-Y.; Hsu M.-C.; Yeh P.-Y.; Wang K.-Y.; Chen T.-S.; Yip P.-K.; Wang V.; Tsai C.-F.; Liu Y.-C.; Chen S.-Y.; Zhao Z.-H.; Wei Z.-P.; Wu S.-L.; Liu C.-K.; Lin R.-H.; Chu C.-H.; Yan S.-H.; Hsiao S.-H.; Yip B.-S.; Tsai P.-C.; Chou P.-C.; Kuo T.-M.; Chiu Y.-P.; Liao Y.-S.; Tsai M.-J.; Kao H.-Y. | Journal of Stroke and Cerebrovascular Diseases | 4 | 4 | |
| 2010 | Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma | Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; SUNG-HSIN KUO ; CHIH-HUNG HSU ; YEN-SHEN LU ; ANN-LII CHENG | Cancer Letters | 19 | 19 | |
| 1996 | Detection of baculovirus associated with white spot syndrome (WSBV) in penaeid shrimps using polymerase chain reaction | You-Tzung Chen; Leu J.-H.; Ho C.-H.; Chen C.-H.; Peng S.-E.; YOU-TZUNG CHEN ; Chou C.-M.; Yeh P.-Y.; Huang C.-J.; Chou H.-Y.; Wang C.-H.; Kou G.-H. | 418 | 400 | ||
| 2007 | Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression | SUNG-HSIN KUO ; Chen L.-T.; MING-SHIANG WU ; KUAN-TING KUO ; KUN-HUEI YEH ; Doong S.-L.; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; CHUNG-WU LIN ; Lin J.-T.; ANN-LII CHENG | Journal of Pathology | 18 | 11 | |
| 2008 | Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells | Chen K.-F.; Yeh P.-Y.; KUN-HUEI YEH ; YEN-SHEN LU ; SHANG-YI HUANG ; ANN-LII CHENG | Cancer Research | 111 | 103 | |
| 2004 | Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy | CHIH-HUNG HSU ; Hsu H.-C.; Chen H.-L.; Gao M.; Yeh P.-Y.; PEI-JER CHEN ; ANN-LII CHENG | Anticancer Research | 47 | 41 | |
| 2005 | Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors | YEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; KUN-HUEI YEH ; Kuo M.-L.; SUNG-HSIN KUO ; ANN-LII CHENG | World Journal of Gastroenterology | 25 | 24 | |
| 2002 | Emulsion synthesis and characterization of lithium cobalt oxide powders for the lithium ion secondary batteries | Lu C.-H. ; Yeh P.-Y. | Key Engineering Materials | 0 | ||
| 2019 | Erythropoietin modulates macrophages but not post-ischemic acute kidney injury in mice | YU-HSIANG CHOU ; Liao F.-L.; YI-TING CHEN ; Yeh P.-Y.; Liu C.-H.; Shih H.-M.; FAN-CHI CHANG ; WEN-CHIH CHIANG ; TZONG-SHINN CHU ; SHUEI-LIONG LIN | Journal of the Formosan Medical Association | 4 | 2 | |
| 2006 | Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity | YEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; SUNG-HSIN KUO ; Chang W.-C.; Kuo M.-L.; ANN-LII CHENG | Lung Cancer | 30 | 29 | |
| 2006 | Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa | YEN-SHEN LU ; Yeh P.-Y.; Chuang S.-E.; Gao M.; Kuo M.-L.; ANN-LII CHENG | Journal of Endocrinology | 23 | 21 | |
| 2010 | Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells | DA-LIANG OU ; Ying-Chun Shen ; SUNG-LIANG YU ; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; LIANG-IN LIN ; CHIUN HSU ; ANN-LII CHENG | Cancer Research | 70 | 68 | |
| 2002 | Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin | CHIH-HUNG HSU ; Hergenhahn M.; Chuang S.-E.; Yeh P.-Y.; Wu T.-C.; Gao M.; ANN-LII CHENG | Anticancer Research | 15 | 13 | |
| 2005 | Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro | CHIH-HUNG HSU ; Gao M.; Chen C.-L.; Yeh P.-Y.; ANN-LII CHENG | Oncology | 39 | 37 | |
| 2013 | Is the renoprotective effect of erythropoietin in chronic kidney disease a myth? | Yeh P.-Y.; Liao F.-L.; SHUEI-LIONG LIN | Journal of the Formosan Medical Association | 7 | 8 | |
| 2011 | IκB kinases increase Myc protein stability and enhance progression of breast cancer cells | Yeh P.-Y.; YEN-SHEN LU ; DA-LIANG OU ; ANN-LII CHENG | Molecular Cancer | 21 | 19 | |
| 2011 | Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001 | SUNG-HSIN KUO ; CHIH-HUNG HSU ; Chen L.-T.; YEN-SHEN LU ; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH ; ANN-LII CHENG | European Journal of Cancer | 16 | 17 |
